EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Gaps and disparities in the treatment of chronic hepatitis B infection in the USA

Robert J Wong iD

Gastroenterology Report · 11.01.2025 · 13

DOI: 10.1093/gastro/goaf016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gastroenterology Report, online erschienen am 06.02.2025. Verfasst von Robert J Wong. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B (CHB) infection affects nearly 300 million individuals worldwide and is a leading cause of hepatocellular carcinoma and liver-related mortality. However, major gaps in the CHB cascade of care persist, with the majority of individuals with CHB not diagnosed and not linked to care and treatment. Even among individuals with known CHB, existing studies report on major gaps and disparities in timely linkage to care and timely access to CHB therapies. While the momentum to expand and simplify CHB treatment guidelines is promising, access to treatment still relies on individuals being effectively engaged in clinical care and liver disease monitoring. The contributing factors to the observed gaps and disparities in the CHB cascade of care are complex and multifactorial, and there is no one-size-fits-all solution than can be easily applied across all global regions. However, any serious approach towards addressing the existing gaps in the CHB cascade of care to improve patient outcomes requires a concerted investment from healthcare institutions, governments, policymakers, and industry partners to provide the necessary resources to be able to achieve this goal. Anything less than a comprehensive and collaborative approach that engages all stakeholders to invest effort and resources into tackling the global epidemic of CHB will continue to fall short in making progress towards global viral hepatitis elimination goals.

Schlagwörter

Stichwörter der Autor:innen

antiviralcascade of caredisparitieshepatitis B

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Gastroenterology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, USA.

ORCID-Profile: Robert J Wong

Zitieren

APA

Wong, R. J. (2025). Gaps and disparities in the treatment of chronic hepatitis B infection in the USA. Gastroenterology Report, 13. https://doi.org/10.1093/gastro/goaf016

Vancouver

Wong RJ. Gaps and disparities in the treatment of chronic hepatitis B infection in the USA. Gastroenterology Report. 2025;13. doi:10.1093/gastro/goaf016

BibTeX
@article{Wong2025,
  author = {Wong, Robert J},
  title = {Gaps and disparities in the treatment of chronic hepatitis B infection in the USA},
  journal = {Gastroenterology Report},
  year = {2025},
  volume = {13},
  doi = {10.1093/gastro/goaf016}
}
Kostenlos starten →